Back to Rankings

PTGX

Protagonist TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
PTGX vs peer average
60/100
PTGX vs. peer average (B vs. C)
Grade spread
A 2 · B 4 · C 1 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

APGE is the first available peer comparator.

Similarly valued development-stage biotech where multiple expansion depends more on clinical and strategic milestone delivery than on current product revenue, though indication overlap is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAPGEApogee Therapeutics
PTGX
Protagonist Therapeutics
APGE
Apogee Therapeutics
Grade
B
C
Momentum
62
60
Value
56
41
Sentiment
60
56
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs APGE

PTGX / APGE
Grade Position
In line
PTGX vs. peer average (B vs. C)
60/100
Momentum
62
PTGX
Value
56
PTGX
Sentiment
60
PTGX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PTGX
1
APGE
APGE
C
60/100
+1
2
CRSP
CRSP
B
80/100
Even
3
IMVT
IMVT
A
100/100
-1
4
PTCT
PTC Therapeutics Inc Common
B
80/100
Even
5
SYRE
Spyre Therapeutics Inc Common
B
80/100
Even
APGE is the first peer returned for this comparison set.